Saturday, December 2, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Medicine & Health

Study reveals how novel coronavirus manipulates cells to replicate

July 18, 2022
in Medicine & Health
0
Share on FacebookShare on Twitter

An article published in the journal Frontiers in Cellular and Infection Microbiology reports a study by researchers at the State University of Campinas (UNICAMP) and the University of São Paulo (USP) in Brazil showing how a human protein interacts with a SARS-CoV-2 protein, and describing one of the ways the virus that causes COVID-19 recruits cells to replicate.

Cell culture trial

Credit: Orlando B. Scudero/ICB-USP

An article published in the journal Frontiers in Cellular and Infection Microbiology reports a study by researchers at the State University of Campinas (UNICAMP) and the University of São Paulo (USP) in Brazil showing how a human protein interacts with a SARS-CoV-2 protein, and describing one of the ways the virus that causes COVID-19 recruits cells to replicate.

In laboratory tests, the researchers inhibited interaction between the molecules using a drug and thereby reduced viral replication by 15%-20%. They expect their findings to contribute to the development of treatments for COVID-19.

“The human protein known as PCNA [proliferating cell nuclear antigen] interacts with the SARS-CoV-2 protein M [matrix], one of the molecules that make up the virus’s membrane and give it shape. The discovery itself shows one of the ways the pathogen manipulates cell function for its life cycle to proceed,” said Fernando Moreira Simabuco, a professor at UNICAMP’s School of Applied Sciences (FCA) in Limeira and principal investigator for the study, which was supported by FAPESP. 

The group used a range of in vitro techniques to investigate how the presence of the viral protein M in the organism makes PCNA, a protein involved in DNA repair, migrate from the cell nucleus, where it is normally found, to the cytoplasm, a cellular region containing organelles responsible for important cell functions.

According to the researchers, this migration shows that the viral and human proteins interact, a conclusion corroborated by other methods, such as use of compounds to inhibit migration of proteins from the nucleus to the cytoplasm. In cells treated with both a specific compound for PCNA and another that inhibits migration of different proteins including PCNA, viral replication was reduced by between 15% and 20% compared with untreated cells. 

“If we’d been thinking about treatment, perhaps this reduction wouldn’t have been significant, but our main aim was to demonstrate the interaction and show that it could be a future therapeutic target,” Simabuco said.

In collaboration with researchers in the Pathology Department of USP’s Medical School, they analyzed samples of lung tissue obtained during autopsies of deceased COVID-19 patients (more at: agencia.fapesp.br/32955/). 

Expression of PCNA was found to be above normal in these samples, as was expression of the protein gamaH2AX, a marker of DNA damage, reinforcing the results.

“This finding may point to yet another consequence of infection by the virus,” Simabuco said.

The first author of the article is Érika Pereira Zambalde, a postdoctoral researcher at FCA-UNICAMP under Simabuco’s supervision.

Protein news

The protein M is anchored, with proteins E and S, in the membrane that envelops SARS-CoV-2, and is the most abundant of its four main structural proteins, called structural because they give it shape. For this reason, it has been considered a potential target for medications and vaccines.

S, the viral spike protein, is well-known because it binds to the ACE receptor in human cells, a role that has made it the target for most current COVID-19 vaccines.

The human protein PCNA is widely studied in the context of cancer research, as exemplified by a project conducted by Simabuco at FCA-UNICAMP. Little is known about the role of PCNA in viral infections, however.

The recently published article, therefore, offers a way forward for further research on this interaction between SARS-CoV-2 and PCNA, facilitating the development of therapies. A next step would be validation of the discoveries in animal models, although this has not yet been programmed.

Some of the experiments were conducted at the Laboratory of Emerging Virus Studies (LEVE) headed by José Luiz Proença Módena at UNICAMP’s Biology Institute (IB), with FAPESP’s support.

Research groups led by Armando Morais Ventura, a professor at USP’s Biomedical Sciences Institute (ICB), and Henrique Marques-Souza, a professor at IB-UNICAMP, collaborated in the study.

About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at www.fapesp.br/en and visit FAPESP news agency at www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.

 

 

 



Journal

Frontiers in Cellular and Infection Microbiology

DOI

10.1186/s12885-016-2629-y

Article Title

Characterization of the interaction between SARS-CoV-2 membrane protein (M) and proliferating cell nuclear antigen (PCNA) as a potential therapeutic target

Article Publication Date

23-May-2022

Tags: cellscoronavirusmanipulatesreplicaterevealsstudy
Share28Tweet18Share5ShareSendShare
  • Tulostoma shaihuludii and a ‘Shai-Hulud’

    Fungus from Arrakis: New species named after Dune’s giant worms

    69 shares
    Share 28 Tweet 17
  • Clinical smart watch finds success at identifying atrial fibrillation

    65 shares
    Share 26 Tweet 16
  • Pathogens use force to breach immune defenses, study finds

    65 shares
    Share 26 Tweet 16
  • Durable plastic pollution easily, cleanly degrades with new catalyst

    65 shares
    Share 26 Tweet 16
  • Research shows human behavior guided by fast changes in dopamine levels

    64 shares
    Share 26 Tweet 16
  • Null results research now published by major behavioral medicine journal

    1152 shares
    Share 461 Tweet 288
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Collaboration between women helps close the gender gap in ice core science

Fungus from Arrakis: New species named after Dune’s giant worms

Null results research now published by major behavioral medicine journal

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In